GlucoModicum today announced positive outcomes from a clinical performance study of its needle-free continuous glucose ...

While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have ...

Senseonics (NYSE:SENS) has offered some insight into its plans for its next-generation implantable continuous glucose ...

Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor ...

One of the leaders in continuous glucose monitoring (CGM) technology, Dexcom (Nadsaq:DXCM) continues to expand its capabilities.

Ypsomed announced today that Chinese regulatory authorities approved the a dual GCP/GLP-1 drug delivered using its ...

A future launch of the dual monitor would only bolster the company’s wide range of diabetes management options. In addition to the leading FreeStyle Libre continuous glucose monitor (CGM) platform, ...

BTIG analysts said today that MiniMed, the Medtronic diabetes business, has some significant pipeline updates.

Additionally, Insulet shared that it has two planned clinical trials for new algorithms for its platforms. One involves ...

Dexcom (Nasdaq:DXCM) has shared a new report highlighting access and attitudes toward type 2 diabetes in the U.S.

t:slim X2, meanwhile, is powered by Control-IQ+ technology. Tandem designed the advanced hybrid closed-loop automated insulin delivery feature to predict and help prevent high and low blood sugar.

(Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.